Study guide
11.2 Central Fill, Centralized Processing & Shared Pharmacy Services
New York MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the NY MPJE Exam 1.2 Study Strategy & Federal vs. New York Law Hierarchy
2 Federal Pharmacy Law: Controlled Substances
2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Registration, Forms & Security 2.3 Federal Food, Drug, and Cosmetic Act (FDCA)
3 Federal Pharmacy Law: Privacy & Supply Chain
3.1 HIPAA & Patient Privacy 3.2 OBRA '90, Medicare/Medicaid & DUR 3.3 DSCSA & Drug Supply Chain Integrity
4 Area 1a: NYSED, Board & Pharmacist Licensure
4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137 4.2 Pharmacist Licensure: Education, NAPLEX/MPJE & Internship 4.3 License by Endorsement, Renewal & Continuing Education
5 Area 1b: Interns, Technicians & Discipline
5.1 Pharmacy Interns & Limited Permits 5.2 Registered Pharmacy Technicians (RPhT) & Supervision Ratios 5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs
6 Area 2a: Prescribing, Controlled Substances & Collaborative Practice
6.1 Prescription Requirements & Practitioner Authority 6.2 Controlled Substance Prescribing & the NY EPCS Mandate 6.3 Refills & Authority Limitations 6.4 Collaborative Drug Therapy Management (§6801-a) & Non-Patient-Specific Orders
7 Area 2b: Counseling, Immunization & Public Health
7.1 Patient Counseling & Documentation 7.2 Pharmacist Immunization Authority 7.3 Naloxone Access & Public Health Programs 7.4 Patient Confidentiality & Pharmacy Records
8 Area 3a: Verification, Transfers & DUR/I-STOP
8.1 Legitimate Medical Purpose & Corresponding Responsibility 8.2 Prescription Transfers Between Pharmacies 8.3 Prospective DUR & the I-STOP PMP Registry 8.4 Refill Exceptions & Emergency Dispensing
9 Area 3b: Labeling, Packaging & Substitution
9.1 Labeling of Dispensed Drugs 9.2 Packaging: PPPA & Child-Resistant Containers 9.3 Generic Substitution & Interchangeable Biologics (§6816-a) 9.4 OTC, Behind-the-Counter & Restricted Nonprescription Sales
10 Area 4a: Records, Inventories & Delivery
10.1 Ordering, Acquisition & Distribution Records 10.2 Recordkeeping, Storage & Handling 10.3 Controlled Substance Inventories & BNE Registration 10.4 Delivery & Mail-Order Dispensing
11 Area 4b: Compounding, Central Fill & Facilities
11.1 Compounding: Non-Sterile, Sterile & Hazardous Drugs 11.2 Central Fill, Centralized Processing & Shared Pharmacy Services 11.3 Automated Dispensing & Telepharmacy 11.4 Pharmacy Establishment Registration, Inspections & Discipline
12 Test-Day Strategy & Final Review
12.1 When New York Law Is Stricter Than Federal Law 12.2 Test-Day Strategy & Common Traps
11.2 Central Fill, Centralized Processing & Shared Pharmacy Services
Key Takeaways Explain This Topic AI
New York never adopted a stand-alone 'central fill' registration class; NYSED withdrew its 2023 draft central fill rule in September 2023 in favor of a statutory fix.
The Governor signed the Shared Pharmacy Services law (Education Law §6809) on November 22, 2024; it took effect May 22, 2026, eighteen months later.
Participating pharmacies must share common ownership or a written contract, give patients signage notice plus one-time consent (with opt-out), and list every participating pharmacy's name and registration number on the label.
NYSED published proposed implementing regulations on September 24, 2025 (comment period through November 23, 2025) to align 8 NYCRR Part 63 with the statute.
In March 2026 the NY Board of Pharmacy (NYBOP) confirmed that both the pharmacy and each individual participating pharmacist — including remote, out-of-state pharmacists — must be separately registered/licensed in New York.
Last updated: July 2026
From Central Fill to "Shared Pharmacy Services"
New York's path to permitting multi-pharmacy prescription processing has been unusually winding, and the history itself is testable because it explains why NY uses the term "shared pharmacy services" rather than "central fill."
Why NY Abandoned the 2023 Central Fill Rule
On June 28, 2023 , NYSED published a proposed regulation that would have created a distinct central fill pharmacy registration class — a facility not open to the public that would only prepare and fill prescriptions forwarded from an "originating" pharmacy, with a bar on direct-to-patient shipping and a requirement that the originating pharmacy obtain the patient's written consent before any prescription went to central fill. NYSED never finalized that rule. On September 12, 2023 , the department announced it was abandoning the regulatory approach and would instead pursue a statutory fix — meaning the underlying authority needed to come from the Legislature, not just a Commissioner's regulation.
Education Law §6809: What It Authorizes
The Legislature answered on November 22, 2024 , when the Governor signed a bill adding Education Law §6809 ("Shared pharmacy services") to Article 137. The statute took effect May 22, 2026 — eighteen months after enactment. Under §6809, a "dispensing" pharmacy may forward some or all of a prescription's processing (verification, drug utilization review, filling) to a "cooperating" pharmacy, which returns it for pickup or delivery to the patient. Participating pharmacies must be registered under Education Law §6805, §6808, or §6808-b, and must either share common ownership or operate under a written contract spelling out each pharmacy's responsibilities, data-sharing terms, and compliance obligations.
Patient Protections
§6809 builds in several patient-facing safeguards:
Requirement Detail
Signage Conspicuous notice (in-person and online) that some/all prescriptions may be processed or filled off premises
Consent One-time written or electronic consent covering current and future prescriptions, documented in the patient's medication profile
- Opt-out Patients may withdraw consent at any time
- Data control Patient data may not be downloaded, duplicated, or removed from a participating pharmacy's system
- Labeling & Recordkeeping
Every pharmacy that touches a shared-services prescription — dispensing and cooperating alike — must have its name and registration number on the finished label. Participating pharmacies must also maintain a tracking system documenting each processing step and every pharmacist, technician, and facility involved, so the Board can reconstruct exactly who did what to a given prescription.
Licensure — The NYBOP Individual-Pharmacist Wrinkle
The most consequential open question after the statute passed was whether an individual pharmacist working for an out-of-state cooperating pharmacy — including one working remotely and never physically present in New York — needs a personal New York pharmacist registration to touch a New York patient's prescription under a shared-services arrangement. In March 2026 , NYBOP confirmed a strict reading: both the pharmacy and each individual pharmacist participating in shared services for New York patients must be separately registered/licensed in New York, grounding the position in Education Law §6802(30) (the definitions provision) and §6809 itself. This is a stricter posture than many other states take toward shared-services and mail-order arrangements, where typically only the pharmacy — not each remote pharmacist — needs in-state registration. Multistate chains must audit which of their remote-processing pharmacists actually hold NY licensure before routing New York prescriptions to them.
Implementing Regulations
NYSED published proposed regulations on September 24, 2025 to conform 8 NYCRR Part 63 to the new statute, with a 60-day public comment period running through November 23, 2025 . Those regulations were expected to be finalized before the May 22, 2026 effective date. MPJE candidates should treat §6809's statutory text — signage, one-time consent with opt-out, dual labeling, tracking, and the NYBOP individual-licensure position — as the settled core, while recognizing that implementing-regulation details may continue to be refined as the rule is finalized.
What Counts as "Processing"
§6809 is deliberately broad about which functions can move to a cooperating pharmacy — the statute speaks in terms of "processing and/or fulfillment" rather than listing discrete clinical tasks. In practice this covers steps such as prescription data entry, prospective drug utilization review, therapeutic verification, and the physical filling of the prescription. It does not relieve either pharmacy of its independent legal duties: the dispensing pharmacy remains responsible for the patient relationship and final release of the prescription, while the cooperating pharmacy is responsible for the steps it actually performs. A pharmacist who verifies a prescription for a shared-services arrangement is exercising professional judgment on that prescription just as if the patient had walked into their own pharmacy, and ordinary standard-of-care and recordkeeping duties travel with the task.
Out-of-State Pharmacies
Any nonresident pharmacy that enters a shared-services arrangement with a New York pharmacy, or that ends up processing or filling New York patients' prescriptions through that arrangement, must separately hold nonresident pharmacy registration in New York (see 11.4) — participation in shared services does not substitute for that registration.
Traps
NY never adopted a separate "central fill" registration class — the 2023 draft was withdrawn; the operative statute is the broader shared pharmacy services law (§6809).
Consent is one-time , not per-prescription, but it must cover current and future prescriptions and remains revocable at any time.
Do not assume only the pharmacy needs NY registration — NYBOP's 2026 position also requires the individual remote pharmacist to be NY-registered.
The label must show every participating pharmacy's name and registration number, not just the dispensing pharmacy's.